Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR‐SB

Abstract There is strong interest in developing predictive models to better understand individual heterogeneity and disease progression in Alzheimer's disease (AD). We have built upon previous longitudinal AD progression models, using a nonlinear, mixed‐effect modeling approach to predict Clinical D...

Полное описание

Библиографические подробности

Главные авторы:	Samira Jamalian, Michael Dolton, Pascal Chanu, Vidya Ramakrishnan, Yesenia Franco, Kristin Wildsmith, Paul Manser, Edmond Teng, Jin Y. Jin, Angelica Quartino, Joy C. Hsu, for the Alzheimer's Disease Neuroimaging Initiative
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wiley 2023-07-01
Серии:	CPT: Pharmacometrics & Systems Pharmacology
Online-ссылка:	https://doi.org/10.1002/psp4.12974
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!